Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: Lupus 2012: New targets, new approaches

Open Badges Meeting abstract

Which lupus trial endpoints best reflect clinical judgment or biomarker improvement?

A Thanou, M Munroe, S Kamp, F Carthen, JA James and JT Merrill*

  • * Corresponding author: JT Merrill

Arthritis Research & Therapy 2012, 14(Suppl 3):A47  doi:10.1186/ar3981

No comments have yet been made on this article.

Post a comment